Press releases
- Press releases
- Browse
Press releases
C200 Inhaler core patent to be granted in Europe. Patent term to 2020. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Oct 2009 - 17 pages - $500
Nov 2011 - 7 pages - $3,835
Oct 2011 - 92 pages - $3,835
Jun 2008 - 175 pages - $3,835
Apr 2009 - 156 pages - $3,800
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Jun 2006 - 1458 pages - $2,495
Oct 2011 - 150 pages - $3,500
Your selection
Browse By
- Therapeutic target
- Aspergillosis
- Bronchitis
- Candidiasis
- Chicken pox
- Chlamydia
- Cholera
- Chronic fatigue syndrome
- Creutzfeldt-Jakob disease
- Diarrhea, bacterial
- Diphtheria
- Ebola hemorrhagic fever
- Encephalitis
- Epstein-Barr virus
- Fever
- Food poisoning
- Gastroenteritis
- Genital warts
- German measles
- Gonorrhea
- Hepatitis A/B
- Hepatitis C/D/E
- HIV
- Infection, bacterial(other)
- Infection, fungal (other)
- Infection, viral (other)
- Infectious disease (other)
- Influenza
- Legionnaire's disease
- Leprosy
- Lyme disease
- Malaria
- Measles
- Meningitis, bacterial
- Meningitis, cryptococcal
- Meningitis, neoplastic
- Meningitis, viral
- Mumps
- Pneumonia
- Polio
- Protozoal diseases (other)
- Pseudomonas lung infection
- Rabies
- Rhinovirus (common cold)
- Rotavirus infection
- Sepsis
- Shingles
- Sinusitis
- Streptococcal infections
- Tetanus
- Trypanosomiasis
- Tuberculosis
- Typhoid
- Urinary tract infection
- Warts
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us